VIRACEPT (AGOURON)
Welcome to the PulseAid listing for the VIRACEPT drug offered from AGOURON. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AGOURON |
NON-PROPRIETARY NAME: | nelfinavir mesylate |
SUBSTANCE NAME: | NELFINAVIR MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-03-14 |
END MARKETING DATE: | 0000-00-00 |
VIRACEPT HUMAN PRESCRIPTION DRUG Details:
Item Description | VIRACEPT from AGOURON |
LABELER NAME: | AGOURON |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 1997-03-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63010-010_6abd808e-1f03-4211-b294-6f596e2585aa |
PRODUCT NDC: | 63010-010 |
APPLICATION NUMBER: | NDA020779 |
Other NELFINAVIR MESYLATE Pharmaceutical Manufacturers / Labelers: